SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,434.07 |
| Enterprise Value ($M) | 1,375.49 |
| Book Value ($M) | 697.02 |
| Book Value / Share | 13.93 |
| Price / Book | 2.06 |
| NCAV ($M) | 691.44 |
| NCAV / Share | 13.82 |
| Price / NCAV | 2.07 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.22 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 28.94 |
| Current Ratio | 28.94 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 716.93 |
| Assets | 722.51 |
| Liabilities | 25.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.52 |
| Operating Income | -178.69 |
| Net Income | -152.09 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -112.31 |
| Cash from Investing | -341.81 |
| Cash from Financing | 453.43 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | EcoR1 Capital, LLC | 0.40 | -94.65 | |
| 13G/A | Point72 Asset Management, L.P. | 9.20 | 83.32 | |
| 13G/A | Fmr Llc | 13.64 | 17.30 | |
| 13G/A | Polaris Partners VII, L.P. | 4.10 | -2.89 | |
| 13G/A | Artal International S.C.A. | 4.30 | -0.55 | |
| 13G | Wellington Management Group Llp | 6.79 | ||
| 13G/A | BlackRock Inc. | 6.60 | 57.95 | |
| 13G | State Street Corp | 5.15 | ||
| 13D | Springer Timothy A | 15.80 | 51.01 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 125,186 | 238,532 | 52.48 | |
| 104,222 | 190,332 | 54.76 | |
| 52,949 | 121,729 | 43.50 | |
| 133,161 | 166,795 | 79.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MIRM – Mirum Pharmaceuticals, Inc. | MNKD – MannKind Corporation |
| MNOV – MediciNova, Inc. | MRNS – Marinus Pharmaceuticals, Inc. |
| MRUS – Merus N.V. |
Financial data and stock pages provided by
Fintel.io